OpenAI-backed Chai raises $70M for AI-driven drug discovery
Summary
Chai, a startup supported by OpenAI, has raised $70 million to advance AI-driven drug discovery. This significant investment highlights growing confidence in AI's potential to accelerate pharmaceutical research and development, signaling increased integration of AI technologies in the healthcare sector.